Trials / Conditions / Secondary AML
Secondary AML
3 registered clinical trials studyying Secondary AML — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myel NCT07250646 | Aspera Biomedicines, Inc. | Phase 1 |
| Completed | Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies NCT00145613 | St. Jude Children's Research Hospital | Phase 2 |
| Approved For Marketing | EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML NCT02533115 | Jazz Pharmaceuticals | — |